Travel Vaccines Market to 2017 – Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market

T

Report Description

The leading business intelligence provider, has released its latest research, “Travel Vaccines Market to 2017 – Growth in International Travel and Higher Incidences of Infectious Diseases in Emerging Economies to Drive the Market”, which provides insights into the global travel vaccines market and market forecasts until 2017. The report provides an in-depth analysis of the top seven therapeutic indications for which travel vaccines are often prescribed, which includes hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis and meningococcal meningitis. In addition, the report also includes insights into the travel vaccines R&D pipeline.

Scope

The scope of this report includes:
Data and analysis on the global travel vaccines market.
Annualized market data for the travel vaccines market from 2002 to 2010, with forecasts to 2017 for top seven geographies which includes the US, the UK, France, Germany, Italy, Spain and Japan.
Market data on the therapeutic landscape which covers hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis and meningococcal meningitis, including market size, market share and cost of vaccination.
Key drivers and restraints that have had a significant impact on the market and on each indication.
The competitive landscape of the global travel vaccine market, which includes companies such as Sanofi-Pasteur, GlaxoSmithKline, Merck, Novartis and Intercell.
Key M&A activities and Licensing Agreements that took place from 2005 to 2011 in the global travel vaccines market.

Reasons to Buy

The report will enhance your decision making capability. It will allow you to
Align your product portfolio to the markets with high growth potential.
Develop market-entry and market expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth.
Devise a more tailored country strategy through the understanding of key drivers and barriers of the region’s antibacterial market.
Develop key strategic initiatives by understanding the key focus areas and top selling antibacterial molecules of leading companies.
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

For more information, please visit :
http://www.aarkstore.com/reports/Travel-Vaccines-Market-to-2017-Growth-in-International-Travel-and-Higher-Incidences-of-Infectious-Diseases-in-Emerging-Economies-to-Drive-the-Market-116639.html

Contact us at :

Aarkstore Enterprise

Tel: +919272852585

Email: [email protected]

Website: www.aarkstore.com

Blog: http://blogs.aarkstore.com/

About the author

By kenneth